A podcast from Washington Post Live, the newsroom’s live journalism platform, where top-level government officials, business leaders, cultural influencers and emerging voices discuss the most pressing issues driving the news cycle nationally and across the globe.
From one-on-one newsmaker interviews to in-depth multi-segment programs, Washington Post Live brings The Post’s newsroom to life.
All content for Washington Post Live is the property of The Washington Post and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A podcast from Washington Post Live, the newsroom’s live journalism platform, where top-level government officials, business leaders, cultural influencers and emerging voices discuss the most pressing issues driving the news cycle nationally and across the globe.
From one-on-one newsmaker interviews to in-depth multi-segment programs, Washington Post Live brings The Post’s newsroom to life.
Colin Murdoch, president of Isomorphic Labs and Ron Alfa, CEO and co-founder of Noetik, join Washington Post Live to discuss the future of diagnostics, precision medicine, the Trump administration's recent cuts to cancer research and the evolution of cancer care.
Conversation recorded on Wednesday, September 17, 2025.
Program sponsored by Pfizer
Washington Post Live
A podcast from Washington Post Live, the newsroom’s live journalism platform, where top-level government officials, business leaders, cultural influencers and emerging voices discuss the most pressing issues driving the news cycle nationally and across the globe.
From one-on-one newsmaker interviews to in-depth multi-segment programs, Washington Post Live brings The Post’s newsroom to life.
